Outcomes of PFA Vs. RFA for Patients with PSVT: a Retrospective and Propensity Score Matching Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorCaijie Shen
About this trial
The goal of this retrospective study is to compare the long-term follow-up outcomes of pulses field ablation (PFA) Vs. radiofrequency ablation (RFA) for the patients with paroxysmal supraventricular tachycardia (PSVT). The main question to answer is:
Does the PFA was more effecient and safer that RFA for treatment of PSVT during procedure and after 1-year follow-up? Researchers will compare the acute and long-term efficiency and safety between PFA and RFA.
1. Recieved PFA or RFA 1 year ago 2. Finish the visit to the clinic at 1, 3, 6, 12 months for examinations and blood testings 3. Patients recieved PFA and PFA under propensity matched comparison according to differen variety of PSVT
Eligibility criteria
Qualifiers
Patients with symptomatic PSVT including: atrioventricular nodal re-entrant tachycardia (AVNRT), atrioventricular re-entrant tachycardia (AVRT);
Age range: 18 years old ≤ age ≤ 80 years old, with no gender restriction;
Willing to receive the examinations and testings during one year follow-up required by the protocol;
Voluntary signed informed consent.
Disqualifiers
Organic heart disease;
History of cardiac surgery;
Previous failed ablation of PSVT;
Presence of any implants, such as a permanent pacemaker;
Trial design
Treatments tested in this trial
- Focal Pulsed Field Ablation (PFA)
- Focal Radiofrequecy Ablation (RFA)
Treatment groups
428 Participants
are divided into 2 treatment groupsSponsors and collaborators
Caijie Shen
Lead sponsor
Ningbo No. 1 Hospital
Sponsor institution
Shanghai MicroPort EP MedTech Co., Ltd.
Collaborator
Source ClinicalTrials.gov